Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trial.

Ortholan C, Aupérin A, Tao Y, Renard S, Pointreau Y, Lafond C, Bera G, Boisselier P, Benezery K, Racadot S, Huguet F, Bollet M, Braccini AL, Khoury C, Jacquot S, Villa J, Martin L, Di Rito A, Wiazzane N, Goineau A, Dupin C, Cartier L, Ruffier A, Cheurfa N, Schwob D, Mertens C, Le Caer H, Bourhis J, Guigay J, Sun XS, ELAN Group including Gustave Roussy, Unicancer GERICO and the H&N groups, and the GORTEC

Open source

DOI: 10.1016/j.lanhl.2025.100812
Published: 2026 Jan
Container: The lancet. Healthy longevity
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lanhl.2025.100812,
  title = {Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trial.},
  author = {Ortholan C and Aupérin A and Tao Y and Renard S and Pointreau Y and Lafond C and Bera G and Boisselier P and Benezery K and Racadot S and Huguet F and Bollet M and Braccini AL and Khoury C and Jacquot S and Villa J and Martin L and Di Rito A and Wiazzane N and Goineau A and Dupin C and Cartier L and Ruffier A and Cheurfa N and Schwob D and Mertens C and Le Caer H and Bourhis J and Guigay J and Sun XS and ELAN Group including Gustave Roussy, Unicancer GERICO and the H\&N groups, and the GORTEC},
  year = {2026},
  journal = {The lancet. Healthy longevity},
  doi = {10.1016/j.lanhl.2025.100812},
  url = {https://doi.org/10.1016/j.lanhl.2025.100812}
}

RIS

TY  - JOUR
TI  - Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trial.
AU  - Ortholan C
AU  - Aupérin A
AU  - Tao Y
AU  - Renard S
AU  - Pointreau Y
AU  - Lafond C
AU  - Bera G
AU  - Boisselier P
AU  - Benezery K
AU  - Racadot S
AU  - Huguet F
AU  - Bollet M
AU  - Braccini AL
AU  - Khoury C
AU  - Jacquot S
AU  - Villa J
AU  - Martin L
AU  - Di Rito A
AU  - Wiazzane N
AU  - Goineau A
AU  - Dupin C
AU  - Cartier L
AU  - Ruffier A
AU  - Cheurfa N
AU  - Schwob D
AU  - Mertens C
AU  - Le Caer H
AU  - Bourhis J
AU  - Guigay J
AU  - Sun XS
AU  - ELAN Group including Gustave Roussy, Unicancer GERICO and the H&N groups, and the GORTEC
PY  - 2026
JO  - The lancet. Healthy longevity
DO  - 10.1016/j.lanhl.2025.100812
UR  - https://doi.org/10.1016/j.lanhl.2025.100812
ER  -

APA

C, O., A, A., Y, T., S, R., Y, P., C, L., G, B., P, B., K, B., S, R., F, H., M, B., AL, B., C, K., S, J., J, V., L, M., A, D. R., N, W., A, G., C, D., L, C., A, R., N, C., D, S., C, M., H, L. C., J, B., J, G., XS, S., & GORTEC, E. G. I. G. R. U. G. A. T. H. G. A. T. (2026). Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trial.. The lancet. Healthy longevity. https://doi.org/10.1016/j.lanhl.2025.100812

Source records

pubmed · retrieved 2026-09-26T17:10:33.702Z